The fund aims to provide long term growth by investing predominantly in the shares of smaller companies listed on the global stock markets.
Name | % Net Assets |
---|---|
Dollarama | 3.1% |
TransDigm Group | 3.0% |
Wabtec | 3.0% |
Paddy Power | 2.7% |
Betsson | 2.7% |
Cosmos Pharmaceutical | 2.6% |
LKQ | 2.6% |
Questcor Pharmaceuticals | 2.5% |
Polaris Industries | 2.5% |
Core Laboratories | 2.5% |
Key | % Net Assets |
---|---|
Dollarama | 3.1% |
TransDigm Group | 3.0% |
Wabtec | 3.0% |
Paddy Power | 2.7% |
Other | 88.2% |
Date | 21-Nov-2024 |
---|---|
NAV | 176.10p |
Currency | GBP |
Change | -1.40p |
% | -0.79% |
YTD change | 16.40p |
YTD % | 10.27% |
Fund Inception | 19/01/2012 |
---|---|
Fund Manager | n/a |
TER | 1.84 (31-Dec-2010) |
Minimum Investment | |
---|---|
Initial | n/a |
Additional | n/a |
Savings | n/a |
Charges | |
---|---|
Initial | n/a |
Annual Mang't | 1.70% |
Exit | n/a |
Name | % |
---|---|
No risk data available. |
You are here: research